Darunavir CAS 206361-99-1 Drugs Used To Treat Pneumonia COA Certification

Basic Information
Place of Origin: CHINA
Brand Name: MOSINTER
Certification: COA
Model Number: Pneumonia Treatment Drugs - 5
Minimum Order Quantity: 25KGS
Price: Negotiation
Packaging Details: Aluminum foil bag , fiber can , kraft paper bag , plastic drum , 1kg/ bag or 25kg/ drum or as required
Delivery Time: Within 7 days
Payment Terms: T/T, Western Union
Supply Ability: 200-300 MTS/month
Detail Information
Name: Darunavir CAS: 206361-99-1
Form: Powder Molecular Formula: C27H37N3O7S
Molecular Weight: 547.66 Type: Pneumonia Treatment Drugs
High Light:

drugs used to treat pneumonia


anti pneumonia drugs

Product Description

Darunavir CAS 206361-99-1 Pneumonia Treatment Drugs




Developed by tibotec, a subsidiary of Johnson & Johnson in the United States, it was first listed in the United States in July 2006. The drug is used in combination with other antiretroviral drugs to treat adult patients with human immunodeficiency virus (HIV) infection.




Items Specifications Results
Impurity at RRT1.3 ≤0.10% N.D
Individual impurity ≤0.50% 0.33%
Total impurities ≤1.0% 0.65%
Assay 97.0%~102.0% 99.60%
Conclusion It conforms to the above specification



Tirenavir is a new non peptide anti retroviral protease inhibitor used in AIDS treatment. It was first developed by tibotec, an Icelandic branch of Johnson & Johnson pharmaceutical. It is the highest bioavailability of six protease inhibitors (xaquinavir, litonavir, indenavir, nafinavir, enrenavir and abt378 / R) at present. It is released from the surface of infected host cells by blocking The formation of new and mature virus particles can inhibit the protease of virus and play a role. When the product is used for a long time, it can usually reduce the HIV vector in the blood, increase the CD4 cell count, reduce the chance of HIV infection, improve the quality of life and prolong life. It is suitable for adults who are infected with HIV but have no curative effect after taking existing antiretroviral drugs. The drug must be used in combination with low-dose ritona chemical Book Wei or other antiretroviral preparations to improve the efficacy. The antiviral activity in vitro can be evaluated by anti acute and chronic infected adult lymphocytes and lymphocytes in peripheral blood. IC50 is 0.012-0.08mmol/l for acute infected cells and 0.41mmol/l for chronic infected cells. Take orally, the recommended dose is 1200mg once, twice a day. The patients with mild to moderate liver dysfunction and those with renal dysfunction should be reduced. The main adverse reactions of tirenavir were gastrointestinal reactions, flushing, pruritus and numbness around the mouth, depression, mood disorder, taste disorder, etc. This product is not recommended for patients with moderate to severe liver dysfunction. Because this component contains sulfanilamide group, it is forbidden for those who are allergic to Sulfanilamide and those who are allergic to any component in the prescription of this product.


Our strengths:


We can customize according to customer's requirement.

If you have any question pls mail us or call us.


Contact Details

Phone Number : +86 18989305995

WhatsApp : +18989305995